BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 37686288)

  • 1. Cancer-Associated Fibroblast Heterogeneity and Its Influence on the Extracellular Matrix and the Tumor Microenvironment.
    Knipper K; Lyu SI; Quaas A; Bruns CJ; Schmidt T
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer.
    Li X; Sun Z; Peng G; Xiao Y; Guo J; Wu B; Li X; Zhou W; Li J; Li Z; Bai C; Zhao L; Han Q; Zhao RC; Wang X
    Theranostics; 2022; 12(2):620-638. PubMed ID: 34976204
    [No Abstract]   [Full Text] [Related]  

  • 3. Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment.
    Bu L; Baba H; Yoshida N; Miyake K; Yasuda T; Uchihara T; Tan P; Ishimoto T
    Oncogene; 2019 Jun; 38(25):4887-4901. PubMed ID: 30816343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumorigenic Interplay Between Macrophages and Collagenous Matrix in the Tumor Microenvironment.
    Varol C
    Methods Mol Biol; 2019; 1944():203-220. PubMed ID: 30840245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal metalloproteinases: Crucial contributors to the tumor microenvironment.
    Shimoda M; Ohtsuka T; Okada Y; Kanai Y
    Pathol Int; 2021 Jan; 71(1):1-14. PubMed ID: 33074556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblasts in the Tumor Microenvironment.
    Truffi M; Sorrentino L; Corsi F
    Adv Exp Med Biol; 2020; 1234():15-29. PubMed ID: 32040852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies.
    Mhaidly R; Mechta-Grigoriou F
    Semin Immunol; 2020 Apr; 48():101417. PubMed ID: 33077325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The extracellular matrix in tumor progression and metastasis.
    Eble JA; Niland S
    Clin Exp Metastasis; 2019 Jun; 36(3):171-198. PubMed ID: 30972526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
    Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal Cell Plasticity and Perfidy in Epithelial Malignancy.
    Puré E; Hingorani SR
    Trends Cancer; 2018 Apr; 4(4):273-277. PubMed ID: 29606311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast heterogeneity and its impact on extracellular matrix and immune landscape remodeling in cancer.
    Yamauchi M; Gibbons DL; Zong C; Fradette JJ; Bota-Rabassedas N; Kurie JM
    Matrix Biol; 2020 Sep; 91-92():8-18. PubMed ID: 32442601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repurposed drug screen identifies cardiac glycosides as inhibitors of TGF-β-induced cancer-associated fibroblast differentiation.
    Coleman DT; Gray AL; Stephens CA; Scott ML; Cardelli JA
    Oncotarget; 2016 May; 7(22):32200-9. PubMed ID: 27058757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of miRNAs in cell signaling of cancer associated fibroblasts.
    Eichelmann AK; Matuszcak C; Hummel R; Haier J
    Int J Biochem Cell Biol; 2018 Aug; 101():94-102. PubMed ID: 29807095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment.
    Monteran L; Erez N
    Front Immunol; 2019; 10():1835. PubMed ID: 31428105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of Liver Metastasis Stiffness Improves Response to Bevacizumab in Metastatic Colorectal Cancer.
    Shen Y; Wang X; Lu J; Salfenmoser M; Wirsik NM; Schleussner N; Imle A; Freire Valls A; Radhakrishnan P; Liang J; Wang G; Muley T; Schneider M; Ruiz de Almodovar C; Diz-Muñoz A; Schmidt T
    Cancer Cell; 2020 Jun; 37(6):800-817.e7. PubMed ID: 32516590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer associated-fibroblast-derived exosomes in cancer progression.
    Li C; Teixeira AF; Zhu HJ; Ten Dijke P
    Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-associated fibroblasts in tumor microenvironment - Accomplices in tumor malignancy.
    Liao Z; Tan ZW; Zhu P; Tan NS
    Cell Immunol; 2019 Sep; 343():103729. PubMed ID: 29397066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-associated fibroblasts: Is it a key to an intricate lock of tumorigenesis?
    Aden D; Zaheer S; Ahluwalia H; Ranga S
    Cell Biol Int; 2023 May; 47(5):859-893. PubMed ID: 36871165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells.
    Lee HO; Mullins SR; Franco-Barraza J; Valianou M; Cukierman E; Cheng JD
    BMC Cancer; 2011 Jun; 11():245. PubMed ID: 21668992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Matrix Revolution: Matricellular Proteins and Restructuring of the Cancer Microenvironment.
    Gerarduzzi C; Hartmann U; Leask A; Drobetsky E
    Cancer Res; 2020 Jul; 80(13):2705-2717. PubMed ID: 32193287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.